Isabel A. E.
- Country
- Spain
- Department
- Pediatric Hemato-Oncology
Research Overview
Data & Insights
Has run more than one trial at 43 of 45 partner sites.
Specializations
Hematologic Oncology
This investigator specializes in the treatment of Acute Myeloid Leukemia (AML), with particular focus on pediatric and adolescent patients. Their clinical interests center on developing innovative therapeutic approaches for young patients with newly diagnosed AML.
- Pediatric AML Treatment
- Adolescent Leukemia Management
- Early Disease Response Assessment
Their expertise extends to evaluating therapeutic strategies that aim to enhance survival outcomes in young AML patients.
Pediatric Oncology
The investigator focuses on advancing treatment protocols for childhood cancer, specifically in the field of myeloid malignancies. Their work emphasizes therapeutic optimization for different risk groups in pediatric populations.
- Risk-Adapted Therapy
- Treatment Protocol Development
- Clinical Response Evaluation
Their clinical interests include developing standardized approaches for treating young patients with hematologic malignancies.
Therapeutic Innovation
The investigator works on evaluating novel therapeutic combinations for blood cancer treatment in young patients. Their focus includes assessment of targeted therapies and optimization of treatment duration.
- Treatment Strategy Optimization
- Therapeutic Response Assessment
- Clinical Protocol Development
Their work involves investigating approaches to enhance treatment efficacy while considering patient outcomes.
Related Investigators
Researchers in similar fields or departments
Want to know more about this investigator?
We can share extended profile information and contact details.
Is something out of date?
Tell us what needs correcting and we'll update this profile.